{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:32:08Z","timestamp":1773145928208,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.3816\/clm.2000.n.004","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:08:55Z","timestamp":1221080935000},"page":"46-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Autologous Stem-Cell Transplantation for Poor-Risk and Relapsed Intermediate- and High-Grade Non-Hodgkin's Lymphoma"],"prefix":"10.3816","volume":"1","author":[{"given":"Auayporn","family":"Nademanee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Dagis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret R.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Spielberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Somlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Sniecinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayana","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Slovak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce C.","family":"Niland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2000.n.004_bib1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2000.n.004_bib2","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.1993.11.10.1846","article-title":"High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non- Hodgkin's lymphoma","volume":"11","author":"Vose","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib3","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V90.10.3844","article-title":"Results of high-dose therapy and autologous bone marrow\/stem cell transplantation during first remission in poor-risk intermediate- and high-grade lymphoma: International Index high and high-intermediate risk group","volume":"90","author":"Nademanee","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.n.004_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2000.n.004_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1200\/JCO.1997.15.3.1131","article-title":"Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2","volume":"15","author":"Haioun","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","article-title":"BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma","volume":"13","author":"Mills","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib7","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1200\/JCO.1994.12.12.2559","article-title":"High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma","volume":"12","author":"Weaver","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib8","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1200\/JCO.1998.16.10.3264","article-title":"Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial","volume":"16","author":"Guglielmi","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V83.5.1165.1165","article-title":"Prognostic factors in aggressive non-Hodgkin's lymphoma: who has \u201chigh-risk\u201d disease?","volume":"83","author":"Shipp","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.n.004_bib10","first-page":"25","article-title":"Cryopreservation and infusion of autologous peripheral blood stem cells","volume":"5","author":"Kessinger","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2000.n.004_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimate from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.3816\/CLM.2000.n.004_bib12","first-page":"5","article-title":"Statistical methods in cancer research. Volume 1\u2013 the analysis of case-control studies","author":"Breslow","year":"1980","journal-title":"IARC Sci Publ"},{"key":"10.3816\/CLM.2000.n.004_bib13","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.1998.16.8.2796","article-title":"VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group","volume":"16","author":"Santini","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib14","first-page":"594a","article-title":"Failure of first line inductive high-dose chemotherapy in poor-risk patients with aggressive lymphoma: updated results of the randomized LNH93-3 study","volume":"90","author":"Reyes","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.n.004_bib15","first-page":"611a","article-title":"High-dose therapy with autologous stem cell transplantation in aggressive NHL: results of a randomized multicenter study","volume":"94","author":"Kaiser","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.n.004_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1200\/JCO.1998.16.1.48","article-title":"Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non- Hodgkin's lymphoma: value of augmented preparative regimens \u2013 a Southwest Oncology Group trial","volume":"16","author":"Stiff","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1200\/JCO.1993.11.6.1085","article-title":"Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and highgrade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide","volume":"11","author":"Wheeler","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib18","first-page":"76","article-title":"Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma","volume":"2","author":"Stockerl-Goldstein","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3816\/CLM.2000.n.004_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1997.15.1.18","article-title":"Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies","volume":"15","author":"Kusnierz-Glaz","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib20","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1200\/JCO.1999.17.12.3793","article-title":"Phase I\/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) Bcell non-Hodgkin's lymphoma","volume":"17","author":"Witzig","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM199310213291702","article-title":"Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support","volume":"329","author":"Press","year":"1993","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2000.n.004_bib22","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.1998.16.10.3270","article-title":"Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue","volume":"16","author":"Liu","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib23","first-page":"3a","article-title":"A phase I\/II trial of high dose iodine-131-anti- B1 (anti-CD20) monoclonal antibody, etoposide, cyclophospha-mide, and autologous stem cell transplantation for patients with relapsed B cell lymphomas","volume":"17","author":"Press","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib24","series-title":"Therapeutic Application of IL-2","first-page":"163","article-title":"Interleukin-2 in the treatment of hematologic malignancies","author":"Benyunes","year":"1993"},{"key":"10.3816\/CLM.2000.n.004_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood.V84.3.957.957","article-title":"Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma","volume":"84","author":"Traweek","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.n.004_bib26","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1200\/JCO.1994.12.12.2535","article-title":"Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma","volume":"12","author":"Stone","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib27","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1994.12.12.2527","article-title":"Incidence and characterization of secondary myelodysplastic syndrome and acute myelogeneous leukemia following high-dose chemoradiotherapy and autologous stemcell transplantation for lymphoid malignancies","volume":"12","author":"Darrington","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib28","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V83.12.3780.3780","article-title":"Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.n.004_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.2000.18.5.947","article-title":"Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies","volume":"18","author":"Micallef","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.n.004_bib30","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood.V95.5.1588.005k38_1588_1593","article-title":"Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors","volume":"95","author":"Krishnan","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.n.004_bib31","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood.V91.12.4496","article-title":"Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study","volume":"91","author":"Mach-Pascual","year":"1998","journal-title":"Blood"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:10Z","timestamp":1761513910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511701993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S1526965511701993"],"URL":"https:\/\/doi.org\/10.3816\/clm.2000.n.004","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous Stem-Cell Transplantation for Poor-Risk and Relapsed Intermediate- and High-Grade Non-Hodgkin's Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLM.2000.n.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}